ArticleScientific reports2026
ROI-guided relational YOLO-SegNet transformer for lightweight bone tumor segmentation and classification from X-ray images.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone tumor detection from X-ray images is challenging due to noise, low contrast, and irregular tumor boundaries that complicate precise segmentation. This study proposes a lightweight Relational YOLO–SegNet framework integrating an Optimized Savitzky–Golay Digital Filter (OSGDF), an ROI-restricted Relational Transformer Block (RTrB), and Fire Hawk Election Optimizer (FHEO)-based hyperparameter tuning. The proposed framework operates as an ROI-guided detection–segmentation pipeline, where YOLOv8 first localizes tumor regions, after which a Relational YOLO–SegNet model performs precise pixel-level segmentation. Image-level classification of normal versus tumor cases is subsequently derived from the segmented regions, making segmentation the primary objective of the framework. The unique contribution of OSGDF lies in its adaptive parameter selection using Tunicate Swarm Optimization, which improves noise suppression while preserving edge sharpness; this resulted in an SNR improvement from 21.4 dB to 29.6 dB, enhancing boundary delineation prior to segmentation. The proposed model applies relational attention only to YOLO-detected tumor regions rather than the entire image token space, reducing computational complexity while maintaining long-range contextual modeling. The framework contains 12.3 million trainable parameters, fewer than conventional encoder–decoder architectures such as UNet and Mask R-CNN. Experiments conducted on a publicly available dataset of 809 X-ray images (421 normal, 388 tumor) with expert-provided pixel-level annotations achieved 98.5% accuracy, 98.32% precision, 98.83% sensitivity (recall), 98.21% specificity, 98.57% F1-score, 97% Dice score, 97.1% Jaccard index, and an AUC of 0.981 under five-fold cross-validation (98.5 ± 0.3%). Statistical analysis confirmed that improvements over baseline models were significant (p < 0.05). The model achieved an inference time of 48 ms per image on an NVIDIA RTX 3090 GPU (24 GB VRAM), demonstrating computational efficiency suitable for resource-constrained deployment scenarios. While the results indicate strong dataset-specific performance, external multi-institutional validation is required before clinical translation. The proposed framework may serve as a potential research-support tool for automated bone tumor analysis using X-ray imaging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.